- Home
- TTD vs KYMR Comparison
TTD vs KYMR Comparison
Compare TTD & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TTD | KYMR |
|---|---|---|
| Founded | 2009 | 2015 |
| Country | United States | United States |
| Employees | 3843 | N/A |
| Industry | Computer Software: Programming Data Processing | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 9.6B |
| IPO Year | 2016 | 2020 |
Fundamental Metrics
Financial Performance| Metric | TTD | KYMR |
|---|---|---|
| Price | $17.29 | $110.57 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 34 | 26 |
| Target Price | $46.22 | ★ $107.72 |
| AVG Volume (30 Days) | ★ 12.6M | 920.7K |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 15.38 | N/A |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $2,896,284,000.00 | $39,211,000.00 |
| Revenue This Year | $13.94 | $10.61 |
| Revenue Next Year | $12.61 | $8.17 |
| P/E Ratio | $210.38 | ★ N/A |
| Revenue Growth | ★ 18.47 | N/A |
| 52 Week Low | $16.70 | $36.88 |
| 52 Week High | $91.45 | $130.05 |
Technical Indicators
Market Signals| Indicator | TTD | KYMR |
|---|---|---|
| Relative Strength Index (RSI) | 39.00 | 54.52 |
| Support Level | $16.98 | $108.87 |
| Resistance Level | $20.54 | $120.90 |
| Average True Range (ATR) | 0.84 | 5.47 |
| MACD | -0.14 | -1.68 |
| Stochastic Oscillator | 19.56 | 22.52 |
Price Performance
Historical ComparisonAbout TTD The Trade Desk Inc.
The Trade Desk provides a self-service platform that helps advertisers and ad agencies programmatically find and purchase digital ad inventory (display, video, audio, and social) on devices like computers, smartphones, and connected TVs. The firm's platform is referred to as a DSP in the digital ad industry, and it generates revenue from fees based on a percentage of what its clients spend on advertising, sometimes referred to as a "take rate".
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.